XML 25 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
Treasury Stock
Accumulated Other Comprehensive Loss
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Balance (in shares) at Sep. 30, 2017     31,503,349            
Balance at Sep. 30, 2017 $ 132,636 $ (107) $ 29 $ 227,264 $ 100   $ (6,431) $ (88,226) $ (207)
Increase (Decrease) in Stockholders' Equity                  
Exercise of common stock options, grants of restricted stock awards, and vesting of restricted stock units (in shares)     973,755            
Exercise of common stock options, grants of restricted stock awards, and vesting of restricted stock units         404   $ 1 403          
Compensation expense and incremental tax benefit from grants of common stock options and restricted stock 6,346     6,346          
Issuance of common stock for acquisition activity (in shares)     297,014            
Issuance of common stock for acquisition activity 2,005   $ 3 2,002          
Net loss (11,615)             (11,615)  
Defined benefit pension plan—unrecognized amounts, net of taxes 773           773    
Foreign currency translation and other (788)           (791) 3  
Balance (in shares) at Sep. 30, 2018     32,774,118            
Balance at Sep. 30, 2018 $ 129,654 $ 730 $ 33 236,115     (6,449) (100,045) $ 730
Increase (Decrease) in Stockholders' Equity                  
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201409Member                
Exercise of common stock options, grants of restricted stock awards, and vesting of restricted stock units (in shares)     953,066            
Exercise of common stock options, grants of restricted stock awards, and vesting of restricted stock units         $ 590   $ 1 589          
Tax settlements associated with stock compensation expense (in shares)     (6,906)            
Taxes paid associated with net settlement of stock compensation awards (44)     (44)          
Forfeiture of restricted stock awards (in shares)     (33,163)            
Stock compensation expense 6,026     6,026          
Net loss (19,260)             (19,260)  
Defined benefit pension plan—unrecognized amounts, net of taxes (540)           (540)    
Foreign currency translation and other (981)           (984) 3  
Balance (in shares) at Sep. 30, 2019     33,687,115            
Balance at Sep. 30, 2019 116,175   $ 34 242,686     (7,973) (118,572)  
Increase (Decrease) in Stockholders' Equity                  
Common stock repurchases (in shares)           (547,508)      
Common stock repurchases (3,983)         $ (3,983)      
Exercise of common stock options, grants of restricted stock awards, and vesting of restricted stock units (in shares)     494,683            
Exercise of common stock options, grants of restricted stock awards, and vesting of restricted stock units         111     111          
Tax settlements associated with stock compensation expense (in shares)     (84,392)            
Taxes paid associated with net settlement of stock compensation awards (594)     (594)          
Forfeiture of restricted stock awards (in shares)     (15,000)            
Forfeiture of restricted stock awards 0                
Stock compensation expense 5,689     5,689          
Net loss (3,774)             (3,774)  
Defined benefit pension plan—unrecognized amounts, net of taxes (2,293)           (2,293)    
Foreign currency translation and other 484           484    
Balance (in shares) at Sep. 30, 2020     34,082,406     547,508      
Balance at Sep. 30, 2020 $ 111,815   $ 34 $ 247,892   $ 3,983 $ (9,782) $ (122,346)  
Increase (Decrease) in Stockholders' Equity                  
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201602Member